Evidence map›Paper›PMID 32781776›Full record

ArticleLife (Basel, Switzerland)2020

Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing.

Mohammad Sabbir Siddiqui, Maxime Francois, Stephanie Rainey-Smith, Ralph Martins, Colin L Masters, David Ames, Christopher C Rowe, Lance S Macaulay, Michael F Fenech, Wayne R Leifert

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Mohammad Sabbir SiddiquiCSIRO Health and Biosecurity, Molecular Diagnostic Solutions, Adelaide SA5005, Australia.
Maxime FrancoisCSIRO Health and Biosecurity, Molecular Diagnostic Solutions, Adelaide SA5005, Australia.ORCID 0000-0003-1317-1506
Stephanie Rainey-SmithCentre of Excellence for Alzheimer's Disease Research & Care, School of Medical Sciences, Edith Cowan University, Joondalup 6027, Australia.
Ralph MartinsCentre of Excellence for Alzheimer's Disease Research & Care, School of Medical Sciences, Edith Cowan University, Joondalup 6027, Australia.
Colin L MastersThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville 3052, Australia.
David AmesNational Ageing Research Institute, Parkville 3052, Australia.
Christopher C RoweDepartment of Nuclear Medicine & Centre for PET, Austin Health, Heidelberg 3084, Australia.
Lance S MacaulayCSIRO Health and Biosecurity, Molecular Diagnostic Solutions, Adelaide SA5005, Australia.
Michael F FenechCSIRO Health and Biosecurity, Molecular Diagnostic Solutions, Adelaide SA5005, Australia.
Wayne R LeifertCSIRO Health and Biosecurity, Molecular Diagnostic Solutions, Adelaide SA5005, Australia.ORCID 0000-0003-0535-7327
CSIRO Health and Biosecurity · AUEdith Cowan University · AUAustin Health · AUNational Ageing Research Institute · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In response to double-stranded breaks (DSBs) in chromosomal DNA, H2AX (a member of histone H2A family) becomes phosphorylated to form γH2AX. Although increased levels of γH2AX have been reported in the neuronal nuclei of Alzheimer's disease (AD) patients, the understanding of γH2AX responses in buccal nuclei of individuals with mild cognitive impairment (MCI) and AD remain unexplored. In the current study, endogenous γH2AX was measured in buccal cell nuclei from MCI (n = 18) or AD (n = 16) patients and in healthy controls (n = 17) using laser scanning cytometry (LSC). The γH2AX level was significantly elevated in nuclei of the AD group compared to the MCI and control group, and there was a concomitant increase in

Indexed as

Alzheimer’s diseaseDNA damagemild cognitive impairmentsenescenceγH2AX

Identifiers

PMID32781776
PMCPMC7459751
OpenAlexW3047482468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.